Stay updated on Pembrolizumab vs Platinum-based Chemo in Urothelial Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab vs Platinum-based Chemo in Urothelial Carcinoma Clinical Trial page.

Latest updates to the Pembrolizumab vs Platinum-based Chemo in Urothelial Carcinoma Clinical Trial page
- Check6 days agoChange DetectedNon-significant updates include the addition of a page revision notice (Revision: v3.3.3) and the removal of the HHS Vulnerability Disclosure link; there are no changes to trial details, outcomes, or user-facing functionality on the record page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check35 days agoChange DetectedRevision: v3.3.2 was added and v3.2.0 was removed from the history; these administrative updates do not modify trial data or page content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check42 days agoChange DetectedThe site-wide notice about government funding and operating status was removed from the page.SummaryDifference0.4%

- Check57 days agoChange DetectedNew history entries were added to the record, but core study data and page structure remain unchanged; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check85 days agoChange DetectedMajor update: new operating-status notice and a v3.2.0 version release, replacing the old v3.1.0.SummaryDifference9%

- Check92 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab vs Platinum-based Chemo in Urothelial Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Platinum-based Chemo in Urothelial Carcinoma Clinical Trial page.